Shares of Colgate-Palmolive Company (NYSE:CL) have earned an average rating of “Hold” from the eighteen analysts that are covering the company. One research analyst has rated the stock with a sell rating, thirteen have given a hold rating and three have issued a buy rating on the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $73.00.

Several equities analysts recently commented on the stock. Barclays PLC restated a “hold” rating and issued a $63.00 price target on shares of Colgate-Palmolive Company in a research note on Tuesday, January 10th. B. Riley restated a “neutral” rating and issued a $74.00 price target on shares of Colgate-Palmolive Company in a research note on Friday, February 3rd. Vetr downgraded shares of Colgate-Palmolive Company from a “hold” rating to a “sell” rating and set a $69.00 price target on the stock. in a research note on Monday, February 20th. Zacks Investment Research upgraded shares of Colgate-Palmolive Company from a “sell” rating to a “hold” rating in a research note on Friday. Finally, Stifel Nicolaus decreased their price target on shares of Colgate-Palmolive Company from $75.00 to $70.00 and set a “hold” rating on the stock in a research note on Monday, January 30th.

Your IP Address:

In other news, Director Stephen I. Sadove sold 8,000 shares of the stock in a transaction dated Friday, February 3rd. The shares were sold at an average price of $66.00, for a total value of $528,000.00. Following the completion of the transaction, the director now owns 33,761 shares of the company’s stock, valued at $2,228,226. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jennifer Daniels sold 868 shares of the stock in a transaction dated Monday, January 9th. The stock was sold at an average price of $66.62, for a total transaction of $57,826.16. Following the completion of the transaction, the insider now directly owns 36,813 shares of the company’s stock, valued at approximately $2,452,482.06. The disclosure for this sale can be found here. Insiders have sold 12,701 shares of company stock worth $838,766 over the last quarter. Corporate insiders own 1.05% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Fundsmith LLP boosted its position in Colgate-Palmolive Company by 7.0% in the second quarter. Fundsmith LLP now owns 1,384,087 shares of the company’s stock worth $100,785,000 after buying an additional 90,358 shares during the period. CAPROCK Group Inc. boosted its position in Colgate-Palmolive Company by 5.1% in the second quarter. CAPROCK Group Inc. now owns 4,087 shares of the company’s stock worth $299,000 after buying an additional 200 shares during the period. IFP Advisors Inc boosted its position in Colgate-Palmolive Company by 1.9% in the second quarter. IFP Advisors Inc now owns 24,660 shares of the company’s stock worth $1,805,000 after buying an additional 453 shares during the period. ST Germain D J Co. Inc. boosted its position in Colgate-Palmolive Company by 15.8% in the second quarter. ST Germain D J Co. Inc. now owns 3,915 shares of the company’s stock worth $287,000 after buying an additional 535 shares during the period. Finally, Personal Capital Advisors Corp boosted its position in Colgate-Palmolive Company by 12.8% in the second quarter. Personal Capital Advisors Corp now owns 267,672 shares of the company’s stock worth $19,594,000 after buying an additional 30,295 shares during the period. 73.24% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Company (NYSE:CL) opened at 73.80 on Tuesday. The company has a market capitalization of $65.15 billion, a P/E ratio of 27.13 and a beta of 0.70. The firm has a 50 day moving average of $70.48 and a 200-day moving average of $69.62. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $75.38.

Colgate-Palmolive Company (NYSE:CL) last released its quarterly earnings results on Friday, January 27th. The company reported $0.75 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.75. Colgate-Palmolive Company had a net margin of 16.06% and a return on equity of 4,897.09%. The business had revenue of $3.72 billion for the quarter, compared to the consensus estimate of $3.87 billion. During the same period in the prior year, the company posted $0.73 earnings per share. Colgate-Palmolive Company’s revenue was down 4.6% compared to the same quarter last year. On average, analysts forecast that Colgate-Palmolive Company will post $2.93 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, May 15th. Shareholders of record on Friday, April 21st will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.17%. This is an increase from Colgate-Palmolive Company’s previous quarterly dividend of $0.39. The ex-dividend date of this dividend is Wednesday, April 19th. Colgate-Palmolive Company’s dividend payout ratio is presently 57.35%.

Colgate-Palmolive Company Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

5 Day Chart for NYSE:CL

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.